Prof. Dr. YAHYA BÜYÜKAŞIK

Yayın Ağı

Makaleler 160

1. Invasive fungal infections in patients with acute leukemia: A retrospective cohort study at a tertiary-care hospital

Alkan A., BÜYÜKAŞIK Y., UZUN Ö., DEMİR A. U., ÇÖPLÜ L.

MEDICINE , cilt.103, sa.40, 2024 (SCI-Expanded, Scopus)

2. An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System

TAŞ Z., METAN G., TELLİ DİZMAN G., Yavuz E., DİZDAR Ö., BÜYÜKAŞIK Y., et al.

ANTIBIOTICS-BASEL , cilt.13, sa.9, 2024 (SCI-Expanded, Scopus)

3. The effect of prognostic features of patients with chronic lymphocytic leukemia on overall survival and treatment-free survival: A single-center experience

Alayvaz Aslan N., BÜYÜKAŞIK Y., SAYINALP N.

Journal of Experimental and Clinical Medicine (Turkey) , cilt.41, sa.1, ss.125-131, 2024 (Scopus)

4. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.

Rheumatology and Therapy , cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)

5. Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study

Arat M., ALACACIOĞLU İ., Bolaman A. Z., BÜYÜKAŞIK Y., Cagirgan S., GÜVENÇ B., et al.

Future oncology (London, England) , cilt.19, sa.14, ss.975-982, 2023 (SCI-Expanded, Scopus)

6. Downregulation of Stearoyl-CoA Desaturase 1 (SCD-1) Promotes Resistance to Imatinib in Chronic Myeloid Leukemia

Gunes B. A., Hekmatshoar Y., ÖZKAN T., Bozkurt S., AYDOS O. S., Buyukasik Y., et al.

Mediterranean Journal of Hematology and Infectious Diseases , cilt.15, sa.1, 2023 (SCI-Expanded, Scopus)

7. A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)

8. Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study

BALABAN H. Y., ASLAN A. T., AKDOĞAN KITTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.7, ss.615-624, 2022 (SCI-Expanded, Scopus, TRDizin)

9. Adenosine Deaminase Type II Deficiency: Severe Chronic Neutropenia, Lymphoid Infiltration in Bone Marrow, and Inflammatory Features.

SÜLEYMAN M., TAN Ç., ÜNER A., Inkaya C., Aytac Ş. S., BÜYÜKAŞIK Y., et al.

Immunological investigations , cilt.51, sa.3, ss.558-566, 2022 (SCI-Expanded, Scopus)

10. Improving Survival Besides the High Early Mortality Rate in Acute Promyelocytic Leukemia

Malkan Ü. Y., Koca E., BÜYÜKAŞIK Y.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.1-7, 2022 (SCI-Expanded, Scopus, TRDizin)

11. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin)

12. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

13. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)

14. Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)

Kayikci O., MEHTAP Ö., Sari I., DEMİRKAN F., Beyan C., ÇETİN G., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.39, sa.3, ss.170-177, 2022 (SCI-Expanded, Scopus, TRDizin)

15. Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia

ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.2, 2021 (SCI-Expanded, Scopus)

16. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors

KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.

CARDIOVASCULAR TOXICOLOGY , cilt.21, sa.3, ss.216-223, 2021 (SCI-Expanded, Scopus)

17. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded, Scopus)

18. Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma

DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., GÖKER H.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.3, ss.204-210, 2021 (SCI-Expanded, Scopus, TRDizin)

19. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

ALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.1, ss.355-358, 2021 (SCI-Expanded, Scopus, TRDizin)

20. Central nervous system involvement in patients with acute myeloid leukemia

YAŞAR H. A., ÇINAR O. E., Koylu N. Y., BARIŞTA İ., GÖKER H., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2351-2356, 2021 (SCI-Expanded, Scopus, TRDizin)

21. Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded, Scopus, TRDizin)

22. Effect of Salvage Chemotherapy Before Donor Lymphocyte Infusion in Patients With Relapse After Allogeneic Hematologic Stem Cell Transplantation

ALADAĞ KARAKULAK E., GÖKER H., BÜYÜKAŞIK Y., DEMİROĞLU H.

TRANSPLANTATION PROCEEDINGS , cilt.53, sa.1, ss.391-395, 2021 (SCI-Expanded, Scopus)

23. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., GÖKER H.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.2, ss.138-144, 2021 (SCI-Expanded, Scopus, TRDizin)

24. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.

OPEN MEDICINE , cilt.16, sa.1, ss.192-197, 2021 (SCI-Expanded, Scopus)

25. Leukocytoclastic vasculitis as a previously unreported paraneoplastic manifestation of acute lymphoblastic leukemia in adults

Ismayilov R., Haziyev T., Ozdemir D. A., Saglam A., BÜYÜKAŞIK Y.

JOURNAL OF HEMATOPATHOLOGY , cilt.13, sa.4, ss.265-268, 2020 (SCI-Expanded, Scopus)

26. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience

Akcay O. F., YETER H. H., BÜYÜKAŞIK Y.

ROMANIAN JOURNAL OF INTERNAL MEDICINE , cilt.58, sa.3, ss.138-145, 2020 (ESCI, Scopus)

27. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience

AKÇAY Ö. F., YETER H. H., BÜYÜKAŞIK Y.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , cilt.58, sa.3, ss.138-145, 2020 (ESCI, Scopus)

28. A unique mutation in the L ferritin coding sequence associated with low serum ferritin level in the presence of normal values of other iron parameters

Ciftciler R., Yilmaz E., BÜYÜKAŞIK Y.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)

29. Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., KARAKULAK U. N., Tekin F., AKSU S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.2, 2020 (SCI-Expanded, Scopus)

30. The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., TOPÇU M., Gevher N., DEMİROĞLU H.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)

31. Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience

GÖKER H., Ciftciler R., DEMİROĞLU H., Turgut M., SAYINALP N., Haznedaroglu I. C., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)

32. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., KARAAĞAÇ AKYOL T., AKSU S., Tekin F., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)

33. The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy

Ciftciler R., HAZNEDAROĞLU İ. C., Ozcebe O., AKSU S., SAYINALP N., GÖKER H., et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , cilt.42, sa.1, ss.17-21, 2020 (SCI-Expanded, Scopus)

34. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)

35. Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

BÜYÜKAŞIK Y., ALİ R., Turgut M., SAYDAM G., Yavuz S., ÜNAL A., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.3, ss.177-185, 2020 (SCI-Expanded, Scopus, TRDizin)

36. Comparison of bortezomib-cyclophosphamide-dexametha-sone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

HEMATOLOGY REPORTS , cilt.12, sa.1, 2020 (ESCI, Scopus)

37. Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.4, ss.256-262, 2020 (SCI-Expanded, Scopus, TRDizin)

38. The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia

Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.116-120, 2020 (SCI-Expanded, Scopus, TRDizin)

39. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., Ozcebe O., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.11, ss.729-734, 2019 (SCI-Expanded, Scopus)

40. SECONDARY MALIGNANCIES IN PATIENTS WITH MULTIPLE MYELOMA

ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., DEMİROĞLU H., AKSU S., GÖKER H.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.94, 2019 (SCI-Expanded, Scopus)

41. Impact of Pre-transplant and Post-transplant Remission Status of Patients on Survival in Newly Diagnosed Multiple Myeloma

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., DEMİROĞLU H.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.35, sa.4, ss.655-661, 2019 (SCI-Expanded, Scopus)

42. Mantle cell lymphoma: a Turkish Multi-Center Study

OKAY M., MELETLİ Ö., KELKİTLİ E., Malkan Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.

JOURNAL OF BUON , cilt.24, sa.5, ss.2084-2089, 2019 (SCI-Expanded, Scopus)

43. Determining the frequency of iron overload at diagnosis in de novo acute myeloid leukemia patients with multilineage dysplasia or myelodysplasia-related changes: a case control study

Yavuz B., Aydin S., Bozkur S., ÜNER A., BÜYÜKAŞIK Y.

JOURNAL OF HEMATOPATHOLOGY , cilt.12, sa.3, ss.135-141, 2019 (SCI-Expanded, Scopus)

44. Severe cytopenia related with the concomitant use of imiquimod and hydroxyurea

GÜLSEREN BÜYÜKDOĞAN D., ELÇİN G., BÜYÜKAŞIK Y.

DERMATOLOGIC THERAPY , 2019 (SCI-Expanded, Scopus)

45. Myeloid maturation potentiates STAT3-mediated atypical IFN-gamma signaling and upregulation of PD-1 ligands in AML and MDS

Yoyen-Ermis D., Tunali G., Tavukcuoglu E., Horzum U., Ozkazanc D., Sutlu T., et al.

SCIENTIFIC REPORTS , cilt.9, 2019 (SCI-Expanded, Scopus)

46. Ghosal hematodiaphyseal dysplasia with autoimmune anemia in two adult siblings

Ciftciler R., BÜYÜKAŞIK Y., Saglam E. A., HAZNEDAROĞLU İ. C.

TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.4, ss.449-452, 2019 (SCI-Expanded, Scopus)

47. TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response

Sener Y., OKAY M., Aydin S., BÜYÜKAŞIK Y., AKBIYIK F., DİKMEN Z. G.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.25, 2019 (SCI-Expanded, Scopus)

48. Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., Saglam E. A., DEMİROĞLU H.

TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.3, ss.313-317, 2019 (SCI-Expanded, Scopus)

49. CYTOGENETIC ANOMALIES IN MULTIPLE MYELOMA PATIENTS: A SINGLE CENTER STUDY

BOZKURT S., BÜYÜKAŞIK Y., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., KARATAŞ A., et al.

Genetics and Application , cilt.3, sa.1, ss.51-56, 2019 (Hakemli Dergi)

50. Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., Gokei H.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.5, 2019 (SCI-Expanded, Scopus)

51. Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors

Gunes G., GÖKER H., DEMİROĞLU H., Malkan Ü. Y., BÜYÜKAŞIK Y.

BONE MARROW TRANSPLANTATION , cilt.54, sa.4, ss.595-600, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.3, ss.177-182, 2019 (SCI-Expanded, Scopus)

53. Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study

Ciftciler R., Sevindik O. G., Tekgunduz A. I. E., ERKURT M. A., VURAL F., TURGUT B., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.3, ss.169-177, 2019 (SCI-Expanded, Scopus, TRDizin)

54. Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia

Ciftciler R., AKSU S., Malkan Ü. Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.29, sa.1, ss.14-21, 2019 (SCI-Expanded, Scopus, TRDizin)

55. The factors affecting early death in newly diagnosed APL patients

Ciftciler R., HAZNEDAROĞLU İ. C., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE , cilt.14, sa.1, ss.647-652, 2019 (SCI-Expanded, Scopus)

56. EBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma

ŞİMŞEK C., BOSTANKOLU B., ÖZOĞUL E., Ayhan A. S., ÜNER A., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.1, ss.57-59, 2019 (SCI-Expanded, Scopus, TRDizin)

57. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study

Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.2, ss.88-96, 2019 (SCI-Expanded, Scopus, TRDizin)

58. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded, Scopus, TRDizin)

59. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency

ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.5, ss.1560-1563, 2019 (SCI-Expanded, Scopus, TRDizin)

60. Indications and outcomes of splenectomy for hematological disorders

Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE , cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded, Scopus)

61. Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., Malkan Ü. Y., Saglam E. A., DEMİROĞLU H.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.12, sa.7, ss.9288-9294, 2019 (SCI-Expanded)

62. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded, Scopus)

63. Evaluation of Secondary Malignancies in Chronic Lymphocytic Leukemia

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.

Journal of Global Oncology , ss.205, 2018 (ESCI)

64. Hemophagocytic Lymphohistiocytosis in Adults: Low Incidence of Primary Neoplasm as a Trigger in a Case Series from Turkey

ARSLAN F., Alp Ş., BÜYÜKAŞIK Y., Ozkan M. C., ŞAHİN F., Basaran S., et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.10, 2018 (SCI-Expanded, Scopus)

65. Monoclonal gammopathy of renal significance presenting as monotypic plasma cell interstitial nephritis in two patients with Sjogren's syndrome

Saglam A., Balaban S., YILDIRIM T., ERDEM Y., ÜNER A., BÜYÜKAŞIK Y.

VIRCHOWS ARCHIV , cilt.472, sa.5, ss.865-869, 2018 (SCI-Expanded, Scopus)

66. Hematopoietic stem cell transplantation in geriatric patients in Turkey

GÖKER H., KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H.

TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.2, ss.159-162, 2018 (SCI-Expanded, Scopus)

67. Polycythemia vera: diagnosis, clinical course, and current management

BÜYÜKAŞIK Y., ALİ R., Cem A. R., Turgut M., Yavuz S., SAYDAM G.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.48, sa.4, ss.698-710, 2018 (SCI-Expanded, Scopus, TRDizin)

68. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded, Scopus, TRDizin)

69. The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia

Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.

LEUKEMIA & LYMPHOMA , cilt.58, ss.96, 2017 (SCI-Expanded)

70. Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.103-104, 2017 (SCI-Expanded, Scopus, TRDizin)

71. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases

Batu E. D., Erden A., Seyhoglu E., KILIÇ L., BÜYÜKAŞIK Y., KARADAĞ Ö., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.46, sa.1, ss.44-48, 2017 (SCI-Expanded, Scopus)

72. TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases

Kulac I., Demir C., BÜYÜKAŞIK Y., Kutluk T., ÜNER A.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.34-39, 2017 (SCI-Expanded, Scopus, TRDizin)

73. Functional exhaustion of CD4(+) T cells induced by co-stimulatory signals from myeloid leukaemia cells

Özkazanç D., Yöyen-Ermiş D., Tavukçuoğlu E., BÜYÜKAŞIK Y., ESENDAĞLI G.

IMMUNOLOGY , cilt.149, sa.4, ss.460-471, 2016 (SCI-Expanded, Scopus)

74. Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients.

HALACLI B., Unver N., HALACLI S., CANPINAR H., ERSOY E., OCAL S., et al.

Journal of critical care , cilt.35, ss.185-90, 2016 (SCI-Expanded, Scopus)

75. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience

Tekgunduz E., GÖKER H., KAYNAR L., SARI İ., Pala C., Dogu M. H., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.16, sa.5, ss.269-274, 2016 (SCI-Expanded, Scopus)

76. Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice

Tekgunduz E., KAYNAR L., GÖKER H., Kaya A. H., ERMİŞ TURAK E., ELİAÇIK E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.41-47, 2016 (SCI-Expanded, Scopus)

77. Chimeric antigen receptor T cell treatment in hematologic malignancies

GÖKER H., Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.35-40, 2016 (SCI-Expanded, Scopus)

78. The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.153-158, 2016 (SCI-Expanded, Scopus, TRDizin)

79. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.2, ss.119-126, 2016 (SCI-Expanded, Scopus, TRDizin)

80. The Impact of Variant Philadelphia Chromosome Translocations on the Clinical Course of Chronic Myeloid Leukemia

Eyupoglu D., BOZKURT S., Haznedaroglu I., BÜYÜKAŞIK Y., Guven D.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.1, ss.60-65, 2016 (SCI-Expanded, Scopus, TRDizin)

81. A new risk scoring model for prediction of poor coronary collateral circulation in acute non-ST-elevation myocardial infarction

Ileri M., Guray U., Yetkin E., Gursoy H. T., Bayir P. T., Sahin D., et al.

CARDIOLOGY JOURNAL , cilt.23, sa.1, ss.107-113, 2016 (SCI-Expanded, Scopus)

82. The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded, Scopus, TRDizin)

83. Venous ulcerations due to inherited fibrinogen disorder in two male siblings

Yildirim S. K., ELÇİN G., BÜYÜKAŞIK Y.

TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY , cilt.50, sa.3, ss.131-134, 2016 (ESCI, Scopus, TRDizin)

84. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin)

85. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

GHASEMİ m., ALPSOY S., TÜRK TÜRK S., MALKAN Ü. Y., ATAKAN Ş., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.286-292, 2016 (SCI-Expanded, Scopus, TRDizin)

86. Chronic liver diseases and iron: a concise review with emphasis on hypotransferrinemia and hypohepcidinemia

Buyukasik N. S., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.46, sa.5, ss.1281-1291, 2016 (SCI-Expanded, Scopus, TRDizin)

87. High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology

BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.102, sa.2, ss.211-217, 2015 (SCI-Expanded, Scopus)

88. Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor

GÖKER H., ETGÜL S., BÜYÜKAŞIK Y.

TRANSFUSION AND APHERESIS SCIENCE , cilt.53, sa.1, ss.23-29, 2015 (SCI-Expanded, Scopus)

89. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia

ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.

HEMATOLOGY , cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded, Scopus)

90. On the association between chronic myelomonocytic leukemia and immune thrombocytopenia: comments on the article by Hadjadj etal.

BÜYÜKAŞIK Y.

EUROPEAN JOURNAL OF HAEMATOLOGY , cilt.94, sa.6, ss.558, 2015 (SCI-Expanded, Scopus)

91. Free Protein S Reference Ranges in Gravidas Without Hereditary and Acquired Thrombophilia

Basaran A., DEREN Ö., BÜYÜKAŞIK Y., Basaran M.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.31, sa.2, ss.286-291, 2015 (SCI-Expanded, Scopus)

92. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded, Scopus, TRDizin)

93. Common variable immune deficiency associated Hodgkin's lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report

Malkan Ü. Y., GÜNEŞ G., Aslan T., ETGÜL S., Aydin S., BÜYÜKAŞIK Y.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.8, ss.14203-14206, 2015 (SCI-Expanded, Scopus)

94. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.

ACTA HAEMATOLOGICA , cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus)

95. The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)

96. Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)

97. Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease

GÜNEŞ G., DEMİROĞLU H., GÖKER H., Malkan Ü. Y., ELİAÇIK E., Yayar O., et al.

CASE REPORTS IN HEMATOLOGY , 2015 (ESCI)

98. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies

Kara O., Zarakolu P., AŞÇIOĞLU HAYRAN S., ETGÜL S., Uz B., BÜYÜKAŞIK Y., et al.

INFECTIOUS DISEASES , cilt.47, sa.10, ss.686-693, 2015 (SCI-Expanded, Scopus)

99. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML

Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.25, sa.4, ss.215-221, 2015 (SCI-Expanded, Scopus, TRDizin)

100. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

101. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)

102. Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded, Scopus, TRDizin)

103. Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report

MALKAN Ü. Y., Gunes G., Eliacik E., ISIK A., AKSU S., ATİLLA B., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.286-288, 2014 (SCI-Expanded, Scopus, TRDizin)

104. Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)

AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.253-259, 2014 (SCI-Expanded, Scopus, TRDizin)

105. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded, Scopus, TRDizin)

106. Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population

Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.190-194, 2014 (SCI-Expanded, Scopus, TRDizin)

107. Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.14, sa.4, ss.308-314, 2013 (SCI-Expanded, Scopus)

108. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded, Scopus, TRDizin)

109. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience

GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded, Scopus)

110. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded, Scopus, TRDizin)

111. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.

HEMATOLOGY , cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded, Scopus)

112. Long-term Follow-up Study in Budd-Chiari Syndrome Single-center Experience in 22 Years

HARMANCI Ö., KAV T., PEYNİRCİOĞLU B., BÜYÜKAŞIK Y., SÖKMENSÜER C., BAYRAKTAR Y.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.8, ss.706-712, 2013 (SCI-Expanded, Scopus)

113. Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis

Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded, Scopus)

114. Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia

BOZKURT S., Uz B., BÜYÜKAŞIK Y., BEKTAŞ Ö., Inanc A., GÖKER H., et al.

MEDICAL ONCOLOGY , cilt.30, sa.1, 2013 (SCI-Expanded, Scopus)

115. Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded, Scopus, TRDizin)

116. Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis

Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded, Scopus, TRDizin)

117. Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study

BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.

ACTA HAEMATOLOGICA , cilt.130, sa.3, ss.199-205, 2013 (SCI-Expanded, Scopus)

118. Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?

YILDIRIM T., Kocak T., BÜYÜKAŞIK Y., Yilmaz R., Altun B., Erdem Y., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.23, sa.8, ss.700-704, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. Extremely high parathyroid hormone concentrations associated with pityriasis rubra pilaris and monoclonal gammopathy of unknown significance: A clinical dilemma

Tanriover M., Portakal O., Hapa A., Tekinel Y., DAĞDELEN S., BÜYÜKAŞIK Y., et al.

BONE , cilt.51, sa.5, ss.847-850, 2012 (SCI-Expanded, Scopus)

120. How do we collect better granulocyte?

Akyol T. K., Buyukasik Y., Aksu S., Ozcebe O. I.

TRANSFUSION AND APHERESIS SCIENCE , cilt.47, sa.1, ss.107-111, 2012 (SCI-Expanded, Scopus)

121. Pre-operative flexion contracture determines the functional outcome of haemophilic arthropathy treated with total knee arthroplasty

ATİLLA B., ÇAĞLAR Ö., Pekmezci M., BÜYÜKAŞIK Y., TOKGÖZOĞLU A. M., ALPASLAN M.

HAEMOPHILIA , cilt.18, sa.3, ss.358-363, 2012 (SCI-Expanded, Scopus)

122. Giant Abdominopelvic Haematoma Arising from Ovulation in a Glanzmann's Thrombasthenia Patient with Platelet Refractoriness: Treatment with Surgery and Intra-Abdominal Tranexamic Acid

BÜYÜKAŞIK Y., BOYRAZ G., Selcuk I., BEKTAŞ Ö., TUNCER Z. S.

ACTA HAEMATOLOGICA , cilt.128, sa.3, ss.154-157, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

123. Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL

Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded, Scopus, TRDizin)

124. Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML

AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded, Scopus, TRDizin)

125. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?

Kutlugun A. A., ALTUN B., BÜYÜKAŞIK Y., AKI F. T., TÜRKMEN E., Altindal M., et al.

TRANSPLANT INTERNATIONAL , cilt.25, sa.1, ss.13-18, 2012 (SCI-Expanded, Scopus)

126. Clinical investigation of oral findings in inherited disorders of platelet function

GÜNGÖR HATİPOĞLU M., Kansu O., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.4, ss.294-298, 2011 (SCI-Expanded, Scopus, TRDizin)

127. Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description

Buyukasik N. S., Nadir I., Akin F. E., Cakal B., KAV T., Ersoy O., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.22, sa.6, ss.606-611, 2011 (SCI-Expanded, Scopus, TRDizin)

128. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria

GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.3, ss.223-227, 2011 (SCI-Expanded, Scopus, TRDizin)

129. Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial

BEKSAÇ M., ALİ R., Ozcelik T., ÖZCAN M., Ozcebe O., Bayik M., et al.

LEUKEMIA RESEARCH , cilt.35, sa.3, ss.340-345, 2011 (SCI-Expanded, Scopus)

130. Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

BÜYÜKAŞIK Y.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.21, sa.2, ss.4-9, 2011 (SCI-Expanded, Scopus, TRDizin)

131. THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.74, sa.1, ss.7-12, 2011 (ESCI, TRDizin)

132. Cutoff Level to Detect Heterozygous Alpha 1 Antitrypsin Deficiency in Turkish Population

ŞİMŞEK H., PINAR A., Altinbas A., Alp A., Balaban Y. H., BÜYÜKAŞIK Y., et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS , cilt.25, sa.4, ss.296-299, 2011 (SCI-Expanded, Scopus)

133. Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES , cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded, Scopus)

134. A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia

Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.20, sa.4, ss.341-344, 2011 (SCI-Expanded, Scopus)

135. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

LEUKEMIA RESEARCH , cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)

136. Increased serum vitamin B-12 levels are associated with adult-onset Still's disease with reactive macrophage activation syndrome

KALYONCU U., BÜYÜKAŞIK Y., AKDOĞAN A., KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., KİRAZ S., et al.

JOINT BONE SPINE , cilt.77, sa.2, ss.131-134, 2010 (SCI-Expanded, Scopus)

137. Chronic Myeloid Leukemia: Practical Issues in Diagnosis, Treatment and Follow-Up

BÜYÜKAŞIK Y., Haznedaroglu I. C., Ilhan O.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.1-12, 2010 (SCI-Expanded, Scopus, TRDizin)

138. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded, Scopus, TRDizin)

139. Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.

MEDICAL ONCOLOGY , cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded, Scopus)

140. DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.73, sa.3, ss.74-79, 2010 (ESCI, TRDizin)

141. Spinal Myeloid Sarcoma in Two Non-Leukemic Patients

Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

INTERNAL MEDICINE , cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded, Scopus)

142. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded, Scopus, TRDizin)

143. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

ANNALS OF HEMATOLOGY , cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded, Scopus)

144. Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.101, sa.4, ss.370-372, 2009 (SCI-Expanded, Scopus)

145. Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.101, sa.3, ss.270-272, 2009 (SCI-Expanded, Scopus)

146. Multiple Bulky Cutaneous Plasmacytomas with CNS Relapse without Bone Marrow Involvement during the Course of a Lambda Light Chain Myeloma

Serefhanoglu S., HAZNEDAROĞLU İ. C., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ.

ONKOLOGIE , cilt.32, sa.11, ss.662-664, 2009 (SCI-Expanded, Scopus)

147. Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.

ANNALS OF HEMATOLOGY , cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded, Scopus)

148. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients

BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.19, sa.7, ss.633-637, 2008 (SCI-Expanded, Scopus)

149. JAK2V617F mutation in patients with portal vein thrombosis

BAYRAKTAR Y., HARMANCI Ö., BÜYÜKAŞIK Y., Shorbagi A. I., Sungur A. H., Boylu C. A., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.53, sa.10, ss.2778-2783, 2008 (SCI-Expanded, Scopus)

150. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts

Koca E., BÜYÜKAŞIK Y., Cetiner D., Yimaz R., Sayinalp N., Yasavul U., et al.

LEUKEMIA RESEARCH , cilt.32, sa.3, ss.495-499, 2008 (SCI-Expanded, Scopus)

151. Evidence for higher red blood cell mass in persons with unconjugated Hyperbilirubinemia and Gilbert's syndrome

BÜYÜKAŞIK Y., Akman U., Buyukasik N. S., GÖKER H., Kilicarslan A., Shorbagi A. I., et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , cilt.335, sa.2, ss.115-119, 2008 (SCI-Expanded, Scopus)

152. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded, Scopus)

153. Congenital dysgranulopoietic neutropenia

Olcay L., Yetgin S., Erdernli E., Germeshausen M., Aktas D., Buyukasik Y., et al.

PEDIATRIC BLOOD & CANCER , cilt.50, sa.1, ss.115-119, 2008 (SCI-Expanded, Scopus)

154. The etiologic distribution of thrombophilic factors in chronic portal vein thrombosis

Harmanci O., Ersoy O., Gurgey A., Buyukasik Y., Gedikoglu G., Balkanci F., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.41, sa.5, ss.521-527, 2007 (SCI-Expanded, Scopus)

155. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia

Koca E., Sevimli F., Cetiner D., Haznedaroglu I. C., Sayinalp N., Buyukasik Y., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.82, sa.4, ss.333, 2007 (SCI-Expanded, Scopus)

156. Research for bleeding tendency in patients presenting with significant epistaxis

Dizdar O., Onal I. K., Ozakin E., Karakilic E., Karadag O., Kalyoncu U., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.18, sa.1, ss.41-43, 2007 (SCI-Expanded, Scopus)

157. Successful plasma exchange treatment in hemolytic crisis of Wilson's disease preventing liver transplantation

Harmanci O., Buyukasik Y., Bayraktar Y.

DIGESTIVE DISEASES AND SCIENCES , cilt.51, sa.7, ss.1230, 2006 (SCI-Expanded, Scopus)

158. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis?

Harmanci O., Buyukasik Y., Kirazli S., Balkanci F., Bayraktar Y.

WORLD JOURNAL OF GASTROENTEROLOGY , cilt.12, sa.8, ss.1273-1277, 2006 (SCI-Expanded, Scopus)

159. No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment

Halil M. G., CANKURTARAN M., YAVUZ B., OZKAYAR N., ULGER Z., DEDE D., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.16, sa.5, ss.349-353, 2005 (SCI-Expanded, Scopus)

160. Treatment of hepatitis B re-activation in lymphoma with lamivudine: A case report and review of the literature Lenfoma seyrinde hepatit B reaktivasyonunun lamivudin ile tedavisi: Bir olgu sunumu ve literatürün gözden geçirilmesi

CANKURTARAN M., ŞİMŞEK H., BÜYÜKAŞIK Y., Tatar G.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.12, sa.1, ss.40-44, 2002 (Scopus, TRDizin) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 60

1. Saf Eritroid Aplazi ile Seyreden Geç Başlangıçlı ADA2 Eksikliği

SOYAK AYTEKİN E., TAN Ç., ÇAĞDAŞ AYVAZ D. N., BÜYÜKAŞIK Y., TEZCAN F. İ.

6. KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 31 - 01 Ekim 2020, (Özet Bildiri)

2. STAT3-mediated atypical IFN-gamma signaling modulates the PD-1 ligands in CD11b-positive subpopulation of MDS and AML cells

Yoyen-Ermis D., Tunali G., Tavukcuoglu E., Ozkazanc D., Sutlu T., BÜYÜKAŞIK Y., et al.

17th International Congress of Immunology of the International-Union-of-Immunological-Societies (IUIS), Beijing, Çin, 19 - 23 Ekim 2019, cilt.49, ss.90, (Özet Bildiri)

3. AZACYTIDINE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS INFERIOR TO HD/ARA-C WITHRESPECT TO RELAPSE FOLLOWING TRANSPLANTATION

DEMİROĞLU H., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÜL Ö., BÜYÜKAŞIK Y., et al.

24th EHA Congress, 13 - 16 Haziran 2019, cilt.3, ss.941-942, (Özet Bildiri)

4. THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE

SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.

15th International Conference on Malignant Lymphoma, İsviçre, 18 - 22 Haziran 2019, cilt.37, ss.366, (Özet Bildiri)

5. ALLOJENİK KÖK HÜCRE NAKLİ SONRASI RELAPS İZLENEN AKUT LÖSEMİ HASTALARINDA TEDAVİ SEÇENEKLERİ: DONÖR LENFOSİT İNFUZYONU VE İKİNCİ ALLOJENİK KÖK HÜCRE NAKLİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., ÇİFTÇİLER R., SAYINALP N., et al.

4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)

6. HEMATOLOJİK MALİGNİTELERDE DONÖR LENFOSİT İNFÜZYONU ÖNCESİ VERİLEN KEMOTERAPİ SİKLUS SAYISININ SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.

4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)

7. MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.

3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Türkiye, 8 - 09 Mart 2019, (Özet Bildiri)

8. Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri)

9. AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.

44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.261, (Özet Bildiri)

10. PHILADELPHIA KROMOZOMU POZİTİF AKUT MYELOİD LÖSEMİLİ OLGU

DEMİROĞLU H., GÖKER H., BÜYÜKAŞIK Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M.

TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)

11. MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.266, (Özet Bildiri)

12. PHİLADELPHİA KROMOZOMU POZİTİF AKUT MYELOİDLÖSEMİLİ OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H., DEMİROĞLU H., BÜYÜKAŞIK Y.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.340, (Özet Bildiri)

13. T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.

TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)

14. LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)

15. DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.364-365, (Özet Bildiri) Sürdürülebilir Kalkınma

16. LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.

44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.191-192, (Özet Bildiri)

17. BRENTIXUMAB VEDOTIN IN CD30 LYMPHOMAS: SINGLE CENTER EXPERIENCE

DEMİROĞLU H., SAYINALP N., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., GÖKER H., et al.

IX. INTERNATIONAL EHOC, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)

18. Descriptive analysis of myeloproliferative diseases and its complications

OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

19. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

20. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.

6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018, (Tam Metin Bildiri)

21. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.

5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Kıbrıs (Kktc), 20 - 22 Eylül 2018, (Özet Bildiri)

22. AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.

4.İLAÇ VE TEDAVİ KONGRESİ, Kıbrıs (Kktc), 19 - 23 Eylül 2018, ss.254, (Özet Bildiri)

23. COMPARISON OF MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.

EUROPEAN HEMATOLOGY ASSOCIATION, 14 - 17 Haziran 2018, (Tam Metin Bildiri)

24. EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

The International Congress of BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, (Özet Bildiri)

25. Compliance to the guideline of diagnostic tests in febrile neutropenic patients at a Turkish university hospital’

ZARAKOLU KÖŞKER I. P., AKOVA M., BÜYÜKAŞIK Y., DURUSU TANRIÖVER M., DİZDAR Ö., METAN G., et al.

20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)

26. Posttransplant Ebstain-Barr viral load monitoring experience in a hematopoietic stem cell transplantation center

AYDIN M. S., Inkaya Çağkan a., ALADAĞ KARAKULAK E., çiftçiler R., TURGUT M., GÖKER H., et al.

European Hematology Association, 14 - 17 Haziran 2018, (Özet Bildiri)

27. RISK FACTORS FOR EARLY MORTALITY IN MULTIPLE MYELOMA WITH DIFFERENT SURVIVAL TIME CUT-OFF POINTS: REAL-LIFE DATA

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., GÖKER H., TURGUT M., et al.

23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)

28. POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER

AYDIN M. S., İNKAYA A. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., TURGUT M., GÖKER H., et al.

23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)

29. ANJİMMUNOBLASTİK T HÜCRELİ LENFOMA, ÇOK YÜZLÜ LENFOMA

OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HEZİYEV T., GÖKER H., BÜYÜKAŞIK Y.

2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)

30. KRONİK LENFOSİTİK LÖSEMİ HASTALARINDA İKİNCİL MALİGNİTELERİN DEĞERLENDİRİLMESİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., HEZİYEV T., BÜYÜKAŞIK Y., SAYINALP N., et al.

2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)

31. PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.

2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)

32. Common medical problems in adult patients with Hemophilia A: A single center experience

AYDIN M. S., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H., et al.

15. INTERNATIONAL HEMOPHILIA CONGRESS OF TURKEY, İstanbul, Türkiye, 4 - 07 Nisan 2018, (Özet Bildiri)

33. Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation

KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H., ŞAHİNER M. L., OKAY M., AYDIN M. S., et al.

59th ASH, 9 - 12 Aralık 2017, cilt.130, ss.5521, (Özet Bildiri)

34. Bağışıklık sistemi baskılanmış hastalarda Microsporidia ve fırsatçı bağırsak parazitlerinin varlığının araştırılması

Kaya F., İNKAYA A. Ç., AKSOY S., ABBASOĞLU O., ERTENLİ A. İ., BÜYÜKAŞIK Y., et al.

4. Ulusal Klinik Mikrobiyoloji Kongresi, Türkiye, 8 - 12 Kasım 2017, (Özet Bildiri)

35. Epidemiological Estimatesand Treatment Practice Pattern in Polycytemia Vera Patients in Turkey:Results Based on an Expert Panel

BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., ÖZET G., Ar C., Özcan M., Güvenç B., et al.

ISPOR 20th Annual European Congress, 4 - 08 Kasım 2017, (Özet Bildiri)

36. The Modelled Effetiveness oh Ruxolitinib on survival in PV Patients with Hydroxyurea Resistance /Intolerancein Turkey

BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., ÖZET G., Ar C., Özcan M., Güvenç B., et al.

ISPOR 20th Annual Eurepean Congress, 4 - 08 Kasım 2017, (Özet Bildiri)

37. Erken Evre Kronik Lenfositer Löseminin Nadir Görünümleri ve Bir Mide Kanseri Vakası Birlikteliği: 2 vaka sunumu.

AYDIN M. S., ÜNER A., OKAY M., MALKAN Ü. Y., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 05 Kasım 2017, cilt.1, ss.66, (Özet Bildiri) Sürdürülebilir Kalkınma

38. Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.

LYMPHOMA MYELOMA 2017, 26 - 28 Ekim 2017, (Özet Bildiri)

39. Monoclonhal gammopathy of renal significance presenting as monotypic plasma cell interststial nephritis in two patients with Sjogren’xxs Syndrome

Balaban S., AYHAN E. A., ÜNER A., OKAY M., BÜYÜKAŞIK Y.

7. Uluslararası Avrasya Hematoloji Kongresi, 13 - 16 Ekim 2017, cilt.61, ss.15, (Özet Bildiri)

40. RARE PRESENTATIONS OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA AND A COINCIDENCE WITH GASTRIC CANCER: 2 CASES

AYDIN M. S., ÜNER A., malkan Ü. Y., OKAY M., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

LEUKEMIA RESEARCH, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16, (Özet Bildiri) Sürdürülebilir Kalkınma

41. MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE PRESENTING AS MONOTYPIC PLASMA CELL INTERTISTIAL NEPHRITIS IN TWO PATIENTS WITH SJÖGREN’S SYNDROME

AYDIN M. S., sağlam a., ÜNER A., OKAY M., BÜYÜKAŞIK Y.

VIII.EURASIAN HEMATOLOGY ONCOLOGY CONGRESS, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16, (Özet Bildiri)

42. EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.

INTERNATIONAL CONGRESS OF BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, cilt.53, (Tam Metin Bildiri)

43. The Impact of Chemo/Immune Therapy-‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia

OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.

iwcll2017, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017, (Özet Bildiri)

44. Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi

ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

2. Hematolojik Onkoloji Kongresi, Kıbrıs (Kktc), 16 - 19 Şubat 2017, (Özet Bildiri)

45. Costimulatory signals derived from myeloid leukemia cells contribute to functional exhaustion in CD4(+) T cells

Ozkazanc D., BÜYÜKAŞIK Y., ESENDAĞLI G.

International Congress of Immunology (ICI), Melbourne, Avustralya, 21 - 26 Ağustos 2016, cilt.46, ss.1092-1093, (Özet Bildiri)

46. Levofloksasin profilaksisi alan hematolojik kanserli nötropenik hastalarda kinolon dirençli Escherichia coli sürveyansı

ETGÜL S., ZARAKOLU KÖŞKER I. P., ESER Ö., KARA Ö., BÜYÜKAŞIK Y., Akova M.

3. Ulusal Klinik Mikrobiyoloji Uzmanlık Derneği Kongresi, Türkiye, 18 - 22 Kasım 2015, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

47. BLEOMYCIN-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORT

Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y.

6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

48. THE COEXISTENCE OF B-THALASSEMIA MINOR AND SICKLE CELL ANEMIA: A CASE REPORT

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., DEMİROĞLU H., BÜYÜKAŞIK Y.

6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

49. PRE-EMPTIVE USAGE OF RITUXIMAB IN A THROMBOTIC THROMBOCYTOPENIC PURPURA CASE

Yayar O., Malkan Ü. Y., Gunes G., Buyukasik Y.

6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

50. Adrenal insufficiency due to antiphospholipid syndrome in a patient with MTHFR

ŞENER Y. Z., ÖZIŞIK L., ERDEN A., KALYONCU U., DURUSU TANRIÖVER M., BÜYÜKAŞIK Y., et al.

14 th Congress European Federation of Internal Medicine, Moskva, Rusya, 14 - 16 Ekim 2015, ss.328-329

51. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., Aktimur S. H., Arica D. C., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.

20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.690, (Özet Bildiri)

52. Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors

Goker H., Gunes G., Demiroglu H., Malkan Ü. Y., Haznedaroglu I., Sayinalp N., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

53. Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Koca E., Halacoglu A., Malkan Ü. Y., Arica D., Karakus S., GÖKER H., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

54. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

55. Treatment resistant autoimmune autonomic ganglionitis associated with increased serum immunoglobulin light chains

Vural A., Senol P. N., BÜYÜKAŞIK Y., ELİBOL B., TUNCER M. A.

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.47, (Özet Bildiri)

56. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.

20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 Haziran 2014, (Tam Metin Bildiri)

57. High-dose chemotherapy and autologons peripheral blood stein tell (PBSC) transplantation with initt-cryopreserved PBSCs in multiple myeloma

Goker H., Eliacik E., Buyukasik Y., Haznedaroglu I. C., Turgut M., Aksu S., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

58. Transfüzyon ilişkili graft versus host hastalığı

Erkuş B., ÖZIŞIK L., HELVACI Ö., ORTAÇ ERSOY N. E., DURUSU TANRIÖVER M., BÜYÜKAŞIK Y., et al.

10. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, İstanbul, Türkiye, 27 - 30 Kasım 2013, ss.64

59. Philadelphia-positive acute lymphoblastic leukemia in daily practice: A multicenter experience.

Goker H., Tekgunduz E., Sari I., Pala C., Dogu M. H., Ozturk E., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

60. Pyrimidine 5' nucleotidase-1 (P5N-1) deficiency associated with 4 novel mutations in 5 new Turkish families: Genotype-phenotype analysis.

Balta G., Gurgey A., Gumruk F., Buyukasik Y., Beksac M., Altay C.

48th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 9 - 12 Aralık 2006, cilt.108, (Özet Bildiri)

Kitaplar 1

1. Klinik Pratikte Hematoloji

HAZNEDAROĞLU İ. C., TURGUT M., GÖKER H., BÜYÜKAŞIK Y.

nobel tıp kitabevleri, Ankara, 2019

Metrikler

Yayın

221

Yayın (WoS)

174

Yayın (Scopus)

154

Atıf (WoS)

675

H-İndeks (WoS)

Atıf (Scopus)

575

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler